Market Survey on Anti-biofilm Wound Dressing Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Anti-biofilm Wound Dressing Market including Physical, Chemical, and Biological Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Anti-biofilm Wound Dressing Market Outlook (2023 to 2033)
The net worth of the market share of the anti-biofilm wound dressing is predicted to reach from US$ 782.60 million in 2023 to over US$ 1939.45 million by 2033, recording a CAGR of 9.5% between 2023 and 2033. Incidence rates for chronic and acute wounds are expected to increase, driving demand for anti-biofilm wound dressings.
As chronic diseases such as diabetes, cancer, and other autoimmune diseases become prevalent. Antimicrobial resistance and unhealthy sedentary lifestyles, tobacco, and alcohol consumption are also contributing to the rising non-communicable disease prevalence.
A study published by the Centres for Disease Control and Prevention in 2020. The report estimates that there are 34.2 million diabetics in the United States which is 10.5% of the population. An estimated 26.8 million people in the United States have been diagnosed with diabetes. However, 7.3 million people have not yet been diagnosed with diabetes, according to a similar report.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Anti-biofilm Wound Dressing Market Dynamics
Telehealth has played a key role in the strong recovery of the wound care market. Various healthcare providers have developed telehealth platforms to effectively manage patients with chronic and acute wounds.
A growing number of chronic and acute wounds caused by chronic diseases (such as diabetes, venous, or arterial disorders) show bacterial contamination films on their surface. This is expected to drive market growth over the forecast period. Hospital-Acquired Pressure Injury (HAPI) accounts for 8.4% of patients with pressure ulcers, according to research published by the National Centre for Biotechnology Information in June 2022.
Several other factors contributing to the market's growth include the development of healthcare infrastructure across developing countries, technological advancements in wound management, and the efforts taken by healthcare providers and key players to increase awareness of wound care.
For instance, according to ASEP Medical Holdings Inc., the Antibiofilm/Anti-inflammatory Peptide Technology that was developed with help from the United States Army Medical Research and Materiel Command was successful in February 2022.
Market growth is expected to be hampered by high costs associated with wound care treatment and a shortage of skilled professionals.
Attributes
Details
Anti-biofilm Wound Dressing Market Value (2023)
US$ 782.60 million
Anti-biofilm Wound Dressing Market Expected Value (2033)
US$ 1939.45 million
Anti-biofilm Wound Dressing Market Projected CAGR (2023 to 2033)
9.5%
Global Anti-biofilm Wound Dressing Market Historical Analysis (2018 to 2022) Vs. Forecast Outlook (2023 to 2033)
According to the World Health Organization, cancer is the leading cause of death worldwide, killing one in six people every year. More than 70 percent of cancer-related deaths occur in countries with low or middle-income groups. Increased incidences of chronic diseases result in prolonged hospitalizations and surgeries, which would increase the demand for anti-biofilm wound dressings.
Due to the increasing participation in sports, injuries are becoming more common. For example, Stanford Children's Health estimates that about 3.5 million injuries occur among children in the United States every year and 21 percent of these injuries are traumatic in nature.
The Canadian Institute for Health Information (CIHI) reports that more than 17,655 individuals have been hospitalized for sports-related injuries in 2017. Therefore, more injuries are occurring to fuel the demand for the global market.
Short Term (2022 to 2025): There is an increase in the number of patients suffering from various disorders due to pandemics, such as eating habits, sedentary lifestyles, and changes in regimes. These factors are negatively impacting human health, leading to chronic diseases such as cancer and diabetes, which are driving the global market.
Medium Term (2025 to 2028): A rising number of people are seeking wound care products, such as anti-biofilm wound dressings, at home. The elderly population is at a significantly higher risk of infection, and the demand for home healthcare products is growing. A growing number of people are turning to online therapies for assistance with their health problems. This is likely to propel the market for anti-biofilm wound dressings into the future.
Long Term (2028 to 2033): The market is predicted to expand during the forecast period due to well-developed healthcare infrastructure and favorable reimbursement policies.
Find your sweet spots for generating winning opportunities in this market.
Comparative Analysis of Adjacent Anti-biofilm Wound Dressing Markets
Anti-biofilm Wound Dressing Market:
Differentiating Aspects
Anti-biofilm Wound Dressing Market
CAGR (2023 to 2033)
9.5%
Market Valuation in 2023
US$ 782.60 million
Projected Market Value in 2033
US$ 1939.45 million
Growth Factors
The rise in the prevalence of chronic illness
Opportunities
Evolving healthcare infrastructure in developing countries
Key Trends
Increased use of telehealth in the management of chronic and acute wounds
Advance Wound Dressing Market:
Differentiating Aspects
Advance Wound Dressing Market
CAGR (2023 to 2033)
4.8%
Market Valuation in 2023
US$ 10333.88 million
Projected Market Value in 2033
US$ 16514.91 million
Growth Factors
Increase in the adoption rate of hydrocolloids and wound contact layers
Opportunities
Increased spending on chronic wounds
Key Trends
Continuously advance improvement in dressing like a combination of antibiotics and painkillers with dressings
Interactive Wound Dressing Market:
Differentiating Aspects
Interactive Wound Dressing Market
CAGR (2023 to 2033)
5.86%
Market Valuation in 2023
US$ 18840 million
Projected Market Value in 2033
US$ 33290 million
Growth Factors
The surge in the number of infections, skin tears, and injuries
Opportunities
The rapid technological advancement by using different types of materials
Key Trends
Growing prevalence of several lifestyle disorders leading to chronic wounds
Major Factors Driving the Anti-biofilm Wound Dressing Market
Diabetes Prevalence to Drive Growth of the Market in the Future
The incidence of diabetic foot ulcers in diabetics ranges from 2% to 10%, according to studies conducted by B Braun Melsungen AG in 2018. The American College of Physicians reports that the number of newly diagnosed cases of diabetic foot ulcers was about 6.3% in 2017. The incidence of diabetic foot ulcers in a lifetime varies from 19% to 34%. Since anti-biofilm dressings are highly recommended for treating chronic wounds, market growth is expected to grow at a high rate.
Most surgical wounds following cancer surgery are deep and large, resulting in exudates that need to be managed daily. As a result, the growing prevalence of chronic illnesses is expected to boost product demand, thus pushing the global anti-biofilm wound dressing market upward. Anti-biofilm wound dressings, such as iodine and silver-based wound dressings, help manage wounds and prevent infection.
according to the World Health Organization (WHO)., about 1,000,000 Indians are affected by serious or moderate burns in India each year, The market may grow due to the rise in injuries caused by road accidents, trauma events, and burns around the globe.
Increasing Prevalence of Chronic Wounds
With the rise of chronic diseases like cancer, diabetes, and Deep Vein Thrombosis (DVT), the likelihood of acquiring chronic wounds rises, which is expected to drive market growth. Diabetic foot ulcers are wounds that typically occur in 15% of diabetic patients.
About 6% of these people are hospitalized due to infection, thus wound treatment is necessary. According to the National Cancer Institute, in 2018, there were 1,735,350 diagnosed cancer cases in the United States. Due to the rise in cancer cases, the demand for anti-biofilm wound dressings may increase.
In the United States, approximately 900,000 people are affected by DVT each year. With the rising prevalence of DVT, patients are more likely to develop venous ulcers. Approximately 20 to 50 percent of them may experience Post-thrombotic Syndrome (PTS), and 5% to 10% may suffer from venous ulcers.
The market is expected to expand further due to the increasing prevalence of pressure ulcers, commonly referred to as bed sores or pressure sores. According to the European Pressure Ulcer Advisory Panel, 5% of community nursing patients and 10% of hospital patients may develop pressure ulcers at some point in their lives. Therefore, the growing prevalence of chronic ulcers is expected to propel the demand for the anti-biofilm wound dressing market.
Ambulatory Surgery Centers are Becoming More Popular
Through the provision of low-risk procedures in a convenient setting, Ambulatory Surgical Centers (ASCs) are revolutionizing healthcare delivery. Thus offering lower costs than other medical settings, such as hospitals, ASCs are anticipated to grow in popularity as Medicare spends more on improving ASCs.
Over 3.4 million Medicare Fee-For-Service (FFS) beneficiaries were treated in 5,603 hospitals certified by Medicare in 2017. Medicare beneficiaries spent US$ 4.6 billion on ASC services in 2017. A growing number of ASCs is expected to drive the overall market. Previously, ASCs offered a single specialty.
There has been an increase in multispecialty ASCs in the United States from 1,802 in 2015 to 1,878 in 2017, as these settings are increasingly used for different applications. Market growth is expected to be driven by the fact that they can perform special treatments, including pain management, orthopedics, and ophthalmology.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Major Restrain Faced by Anti-biofilm Wound Dressing Market: The Rise in Treatment Cost
The number of wound patients occupying hospital beds is approximately 25% to 40%. A wound takes a long time to heal and requires many resources. The human cost associated with wounds is prolonged hospital stays, chronic pain, and distress.
For example, a stage IV pressure ulcer causes considerable pain, adding around three months or longer to hospital stays, thereby increasing the patient burden. Similarly, wound infections can lead to inflammation and pain, which will require surgical intervention or anti-biofilm dressings to prevent wound infections from developing.
The cost of wound care in acute settings can reach 15% to 20% of materials, 30% to 35% of nurse time, and more than 50% of hospitalization. The wound dressings must be changed frequently, which adds to the cost of treatment.
It is estimated that chronic wounds cost between US$ 3.48 million and US$ 4.32 million per year, accounting for about 2% to 3% of the healthcare budget. As a result, high treatment costs may result in a decrease in the adoption of anti-biofilm wound dressings, which, in turn, may hinder the market growth during the forecast period.
Major Opportunities for Anti-biofilm Wound Dressing Market: Rise in Accident Cases
Approximately 50 million people are affected annually by vehicle accidents, including slips, trips, burns, and road accidents. Wound dressings that promote wound healing and are anti-biofilm, the market is driven by the increase in accidents, slips, trips, burns, and other ailments.
Health and Safety Middle East (HSME) indicates that hundreds of workers suffer injuries in the workplace each year as a result of trips, slips, and falls. An increase in burn injuries is also expected to drive the market's growth. It is estimated that 1.1 million burn injuries occur in the United States every year. Approximately 50,000 of these patients require hospitalization, which increases the need for wound dressings with anti-biofilms.
The global anti-biofilm wound dressing devices market is segmented by mode of mechanism, wound type, end-user, and region.
Expanding the Penetration of Chemical Segment:
Based on the Mode of Mechanism: The global anti-biofilm wound dressing devices market has been segmented into physical, chemical, and biological. The chemical segment is expected to dominate the overall market and record a significant CAGR of 9.9% during the forecast period.
The chemical mode of mechanism is expected to expand substantially over the forecast period. There is a growing prevalence of chronic wounds and a growing number of surgeries worldwide, so this is inevitable.
A chemical-based anti-biofilm wound dressing improves wound healing efficiency and recovery efficiency by targeting biofilms on multiple levels. They can reduce the accumulation of biofilm on wounds and reduce the risk of recontamination with microorganisms.
A significant increase in Research and Development activities and innovation is taking place in the anti-biofilm wound dressing industry, which is fuelled by the physical mode of mechanism. It was announced in June 2020 that the United Kingdom National Biofilms Innovation Centre would be providing a grant of US$ 28,949.03 million for research and the introduction of enhanced product lines related to managing, engineering, and detecting biofilms. There are three types of physical modes of debridement: manual debridement, pulse electrical field debridement, and ultrasound debridement.
The Acute Wounds Segment Dominate the Anti-biofilm Wound Dressing Market
Based on wound type, the anti-biofilm wound dressing market is segmented into acute and chronic wounds. In 2023, surgical & traumatic wounds held a significant share, due to the increasing number of trauma cases worldwide. The acute wound segment dominated the market. This segment is expected to grow by 9.3%.
Traumatic wounds are sudden injuries that can range from minor ones to severe ones, like gunshot wounds. Such wounds include abrasions, lacerations, skin tears, bites, and penetrating trauma wounds. Anti-biofilm wound dressings are ideal for treating these types of wounds.
When treating traumatic wounds with these dressings, the body's underlying tissues are repaired, foreign particles are removed, and wounds are allowed to drain. Preventing infections and promoting healing, these steps can promote segment growth and help prevent infections.
Regions Leading in Anti-biofilm Wound Dressing Market: Country-Wise Analysis
Region
North America
Country
The United States
CAGR
9.5%
Region
Europe
Country
Germany
CAGR
8.6%
Region
Europe
Country
The United Kingdom
CAGR
9.1%
Anti-biofilm Wound Dressing Market Outlook in the United States
The United States accounts for a significant market share in North America r and is estimated to record a CAGR of 9.5%. An increase in chronic wounds, a rise in road accidents, and the presence of large ambulatory surgical centers are a few factors that drive market growth in this region. Well-developed infrastructure, skilled staff, and increased healthcare expenditures contribute to this region's market growth.
Anti-biofilm Wound Dressing Market is Becoming Mainstream in the United Kingdom
Europe's significant region, the United Kingdom, is expected to record a CAGR of 9.1%. Wounds are a growing concern in Europe, and their treatment involves a variety of resources. Various surveys were conducted in the United Kingdom.
According to statistics, three to four wounds per 1,000 people are reported. Diabetic foot ulcers are estimated to be diagnosed between 400,000 and 600,000 each year, along with venous leg ulcers that number about one million.
The United Kingdom's anti-biofilm wound dressing market is expected to grow due to the aging population and the increased prevalence of long-term chronic conditions.
Promising Market Share of Anti-biofilm Wound Dressing in China
Various studies conducted in China estimate that around 100 million patients require wound care every year, and about 30 million of these are skin wounds. These factors are expected to drive the market in China. An increase in healthcare expenditure, an increase in road accidents, and a significant amount of patient population are expected to drive the market.
The number of wound care centers in China has increased from 16 in 2010 to 357 in 2019. In December 2019, the National Health Commission of China released a notice for promoting the management of diagnosis and treatment of chronic skin wounds. This system includes setting up wound treatment departments and training specialized doctors & nurses.
The population of China is covered by social health insurance for more than 95%, which includes all primary healthcare institutions, public hospitals, as well as some private hospitals. As a result, chronic wounds are on the rise in China, government initiatives are being implemented, and healthcare facilities are being improved, which is expected to drive the market.
Start-up Ecosystem: The Anti-biofilm Wound Dressing Market
It seems that several new industry players are concentrating their efforts on consolidating their distribution channels. They are also focusing on direct marketing as a way of getting a foothold in the anti-biofilm wound dressing market.
To gain an advantage over their competitors, numerous key players are still focusing on partnerships and innovation in product development as their primary strategies to gain an advantage over their competitors.
For instance, a telehealth platform developed by Wound Pros Inc. in January 2021 enables patients and professionals to communicate. Their app, RITA, facilitates new wound measurements and diagnostics.
Competitive Landscape
Inflows of Funds are Expected as Market Players Expand their Footprints
Leading companies are leaving no stone unturned to gain a competitive edge and boost the anti-biofilm wound dressing market outlook.
For Instance:
Triad Life Sciences Inc. was acquired by Convatec Inc. for US$ 450 million in March 2022. With the acquisition, Convatec intends to strengthen its portfolio of biologically derived innovative products for surgical wounds, chronic wounds, and burns.
A newly FDA-cleared antimicrobial matrix product from Imbed Biosciences, Microlyte Matrix, was announced in April 2021. The product is intended for use in the treatment of surgical, traumatic, and chronic wounds.
The ConvaTec Group Plc (ConvaTec) launched an innovative new medication called "ConvaMax" in January 2020 to treat diabetic foot ulcers, pressure ulcers, leg ulcers, and dehisced surgical wounds. The product is available in non-adhesive forms as well, allowing total freedom when integrating compression bands or a main dressing to support the care regimen.
Microlyte Ag was introduced to the market in January 2018, after Imbed Biosciences raised more than USD 1.6 million to research silver-based anti-biofilm wound dressings.
Smith & Nephew PLC acquired Osiris Therapeutics, Inc. in April 2019, a company specializing in regenerative medicine. As a result of this acquisition, the company will expand its product portfolio for advanced wound management, increasing the company's market share and customer base. This initiative is intended to boost the company's growth.
Some of the Prominent Players in the Anti-Biofilm Wound Dressing Market are as Follows
ConvaTec
Smith & Nephew PLC
Urgo Medical
Coloplast
3M
Scope of Report
Attribute
Details
Forecast Period
2023 to 2033
Historical Data Available for
2018 to 2022
Market Analysis
US$ million for Value and MT for Volume
Key Regions Covered
North America
Latin America
Europe
The Middle East and Africa (MEA)
East Asia
Key Countries Covered
The United States, Canada, Brazil, Mexico, Chile, Peru, Germany, The United Kingdom., Spain, Italy, France, Russia, Poland, China, India, Japan, Australia, New Zealand, GCC Countries, North Africa, and South Africa
Key Segments Covered
Mode of Mechanism
Wound Type
End User
Region
Key Companies Profiled
ConvaTec
Smith & Nephew PLC
Urgo Medical
Coloplast
3M
Report Coverage
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing
Available upon Request
Anti-biofilm Wound Dressing Market Segmentation by Category
By Mode of Mechanism:
Physical
Chemical
Biological
By Wound Type:
Chronic Wounds
Acute Wounds
By End User:
Hospitals and Clinics
Surgical Centers
Other End users
By Region:
North America
Latin America
Europe
The Middle East & Africa (MEA)
East Asia
Frequently Asked Questions
What is the Current Magnitude of the Anti-biofilm Wound Dressing Market?
The market is valued at US$ 782.6 million in 2023.
What is the Anticipated Market Size by 2033?
The market is anticipated to secure a valuation of US$ 1,939.45 million by 2033.
Which Segment is Likely to Lead the Anti-biofilm Wound Dressing Market by Mode of Mechanism?
The chemical segment is expected to lead the market with a CAGR of 9.9% during the forecast period.
Which are the Key Asian Countries in the Anti-biofilm Wound Dressing Market?
India, Japan, and China dominate the Asian market.
Table of Content
1. Executive Summary | Anti-biofilm Wound Dressing Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Mode of Mechanism
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Mode of Mechanism, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Mode of Mechanism, 2023 to 2033
5.3.1. Physical
5.3.1.1. Manual Debridement
5.3.1.2. Pulse Electrical Field
5.3.1.3. Ultrasound Debridement
5.3.2. Chemical
5.3.2.1. Ionic Silver
5.3.2.2. Iodine
5.3.2.3. EDTA
5.3.2.4. Others
5.3.3. Biological
5.3.3.1. Dispersin B
5.3.3.2. Lactoferrin
5.3.3.3. Bacteriophage
5.3.3.4. Others
5.4. Y-o-Y Growth Trend Analysis By Mode of Mechanism, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Mode of Mechanism, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Chronic Wounds
6.3.1.1. Diabetic Foot Ulcers
6.3.1.2. Pressure Ulcers
6.3.1.3. Venous Leg Ulcers
6.3.1.4. Others
6.3.2. Acute Wounds
6.3.2.1. Surgical & Traumatic Wounds
6.3.2.2. Burn Wounds
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-use
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End-use, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-use, 2023 to 2033
7.3.1. Hospitals
7.3.2. Specialty Clinics
7.3.3. Home Healthcare
7.3.4. Others
7.4. Y-o-Y Growth Trend Analysis By End-use, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End-use, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East & Africa (MEA)
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Mode of Mechanism
9.2.3. By Application
9.2.4. By End-use
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Mode of Mechanism
9.3.3. By Application
9.3.4. By End-use
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Mode of Mechanism
10.2.3. By Application
10.2.4. By End-use
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Mode of Mechanism
10.3.3. By Application
10.3.4. By End-use
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Mode of Mechanism
11.2.3. By Application
11.2.4. By End-use
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Mode of Mechanism
11.3.3. By Application
11.3.4. By End-use
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Singapore
12.2.1.5. Thailand
12.2.1.6. Indonesia
12.2.1.7. Australia
12.2.1.8. New Zealand
12.2.1.9. Rest of Asia Pacific
12.2.2. By Mode of Mechanism
12.2.3. By Application
12.2.4. By End-use
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Mode of Mechanism
12.3.3. By Application
12.3.4. By End-use
12.4. Key Takeaways
13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Mode of Mechanism
13.2.3. By Application
13.2.4. By End-use
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Mode of Mechanism
13.3.3. By Application
13.3.4. By End-use
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By Mode of Mechanism
14.1.2.2. By Application
14.1.2.3. By End-use
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By Mode of Mechanism
14.2.2.2. By Application
14.2.2.3. By End-use
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By Mode of Mechanism
14.3.2.2. By Application
14.3.2.3. By End-use
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By Mode of Mechanism
14.4.2.2. By Application
14.4.2.3. By End-use
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By Mode of Mechanism
14.5.2.2. By Application
14.5.2.3. By End-use
14.6. UK
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By Mode of Mechanism
14.6.2.2. By Application
14.6.2.3. By End-use
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By Mode of Mechanism
14.7.2.2. By Application
14.7.2.3. By End-use
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By Mode of Mechanism
14.8.2.2. By Application
14.8.2.3. By End-use
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By Mode of Mechanism
14.9.2.2. By Application
14.9.2.3. By End-use
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By Mode of Mechanism
14.10.2.2. By Application
14.10.2.3. By End-use
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By Mode of Mechanism
14.11.2.2. By Application
14.11.2.3. By End-use
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By Mode of Mechanism
14.12.2.2. By Application
14.12.2.3. By End-use
14.13. Singapore
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By Mode of Mechanism
14.13.2.2. By Application
14.13.2.3. By End-use
14.14. Thailand
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By Mode of Mechanism
14.14.2.2. By Application
14.14.2.3. By End-use
14.15. Indonesia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By Mode of Mechanism
14.15.2.2. By Application
14.15.2.3. By End-use
14.16. Australia
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2022
14.16.2.1. By Mode of Mechanism
14.16.2.2. By Application
14.16.2.3. By End-use
14.17. New Zealand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2022
14.17.2.1. By Mode of Mechanism
14.17.2.2. By Application
14.17.2.3. By End-use
14.18. GCC Countries
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2022
14.18.2.1. By Mode of Mechanism
14.18.2.2. By Application
14.18.2.3. By End-use
14.19. South Africa
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2022
14.19.2.1. By Mode of Mechanism
14.19.2.2. By Application
14.19.2.3. By End-use
14.20. Israel
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2022
14.20.2.1. By Mode of Mechanism
14.20.2.2. By Application
14.20.2.3. By End-use
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Mode of Mechanism
15.3.3. By Application
15.3.4. By End-use
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. ConvaTec Inc.
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. Smith & Nephew PLC
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Urgo Medical
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Coloplast
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. 3M
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Mölnlycke Health Care AB
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Imbed Biosciences
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Next Science
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. B. Braun Melsungen AG
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. Lohmann & Rauscher
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used18. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033
Table 2: Global Market Value (US$ Million) Forecast by Mode of Mechanism, 2018 to 2033
Table 3: Global Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 4: Global Market Value (US$ Million) Forecast by End-use, 2018 to 2033
Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 6: North America Market Value (US$ Million) Forecast by Mode of Mechanism, 2018 to 2033
Table 7: North America Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 8: North America Market Value (US$ Million) Forecast by End-use, 2018 to 2033
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 10: Latin America Market Value (US$ Million) Forecast by Mode of Mechanism, 2018 to 2033
Table 11: Latin America Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 12: Latin America Market Value (US$ Million) Forecast by End-use, 2018 to 2033
Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 14: Europe Market Value (US$ Million) Forecast by Mode of Mechanism, 2018 to 2033
Table 15: Europe Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 16: Europe Market Value (US$ Million) Forecast by End-use, 2018 to 2033
Table 17: Asia Pacific Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 18: Asia Pacific Market Value (US$ Million) Forecast by Mode of Mechanism, 2018 to 2033
Table 19: Asia Pacific Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 20: Asia Pacific Market Value (US$ Million) Forecast by End-use, 2018 to 2033
Table 21: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033
Table 22: MEA Market Value (US$ Million) Forecast by Mode of Mechanism, 2018 to 2033
Table 23: MEA Market Value (US$ Million) Forecast by Application, 2018 to 2033
Table 24: MEA Market Value (US$ Million) Forecast by End-use, 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Mode of Mechanism, 2023 to 2033
Figure 2: Global Market Value (US$ Million) by Application, 2023 to 2033
Figure 3: Global Market Value (US$ Million) by End-use, 2023 to 2033
Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033
Figure 8: Global Market Value (US$ Million) Analysis by Mode of Mechanism, 2018 to 2033
Figure 9: Global Market Value Share (%) and BPS Analysis by Mode of Mechanism, 2023 to 2033
Figure 10: Global Market Y-o-Y Growth (%) Projections by Mode of Mechanism, 2023 to 2033
Figure 11: Global Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 14: Global Market Value (US$ Million) Analysis by End-use, 2018 to 2033
Figure 15: Global Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033
Figure 16: Global Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033
Figure 17: Global Market Attractiveness by Mode of Mechanism, 2023 to 2033
Figure 18: Global Market Attractiveness by Application, 2023 to 2033
Figure 19: Global Market Attractiveness by End-use, 2023 to 2033
Figure 20: Global Market Attractiveness by Region, 2023 to 2033
Figure 21: North America Market Value (US$ Million) by Mode of Mechanism, 2023 to 2033
Figure 22: North America Market Value (US$ Million) by Application, 2023 to 2033
Figure 23: North America Market Value (US$ Million) by End-use, 2023 to 2033
Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 28: North America Market Value (US$ Million) Analysis by Mode of Mechanism, 2018 to 2033
Figure 29: North America Market Value Share (%) and BPS Analysis by Mode of Mechanism, 2023 to 2033
Figure 30: North America Market Y-o-Y Growth (%) Projections by Mode of Mechanism, 2023 to 2033
Figure 31: North America Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 34: North America Market Value (US$ Million) Analysis by End-use, 2018 to 2033
Figure 35: North America Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033
Figure 37: North America Market Attractiveness by Mode of Mechanism, 2023 to 2033
Figure 38: North America Market Attractiveness by Application, 2023 to 2033
Figure 39: North America Market Attractiveness by End-use, 2023 to 2033
Figure 40: North America Market Attractiveness by Country, 2023 to 2033
Figure 41: Latin America Market Value (US$ Million) by Mode of Mechanism, 2023 to 2033
Figure 42: Latin America Market Value (US$ Million) by Application, 2023 to 2033
Figure 43: Latin America Market Value (US$ Million) by End-use, 2023 to 2033
Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 48: Latin America Market Value (US$ Million) Analysis by Mode of Mechanism, 2018 to 2033
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Mode of Mechanism, 2023 to 2033
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Mode of Mechanism, 2023 to 2033
Figure 51: Latin America Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 54: Latin America Market Value (US$ Million) Analysis by End-use, 2018 to 2033
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033
Figure 57: Latin America Market Attractiveness by Mode of Mechanism, 2023 to 2033
Figure 58: Latin America Market Attractiveness by Application, 2023 to 2033
Figure 59: Latin America Market Attractiveness by End-use, 2023 to 2033
Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033
Figure 61: Europe Market Value (US$ Million) by Mode of Mechanism, 2023 to 2033
Figure 62: Europe Market Value (US$ Million) by Application, 2023 to 2033
Figure 63: Europe Market Value (US$ Million) by End-use, 2023 to 2033
Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033
Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 68: Europe Market Value (US$ Million) Analysis by Mode of Mechanism, 2018 to 2033
Figure 69: Europe Market Value Share (%) and BPS Analysis by Mode of Mechanism, 2023 to 2033
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Mode of Mechanism, 2023 to 2033
Figure 71: Europe Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 72: Europe Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 74: Europe Market Value (US$ Million) Analysis by End-use, 2018 to 2033
Figure 75: Europe Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033
Figure 76: Europe Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033
Figure 77: Europe Market Attractiveness by Mode of Mechanism, 2023 to 2033
Figure 78: Europe Market Attractiveness by Application, 2023 to 2033
Figure 79: Europe Market Attractiveness by End-use, 2023 to 2033
Figure 80: Europe Market Attractiveness by Country, 2023 to 2033
Figure 81: Asia Pacific Market Value (US$ Million) by Mode of Mechanism, 2023 to 2033
Figure 82: Asia Pacific Market Value (US$ Million) by Application, 2023 to 2033
Figure 83: Asia Pacific Market Value (US$ Million) by End-use, 2023 to 2033
Figure 84: Asia Pacific Market Value (US$ Million) by Country, 2023 to 2033
Figure 85: Asia Pacific Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 86: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 87: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 88: Asia Pacific Market Value (US$ Million) Analysis by Mode of Mechanism, 2018 to 2033
Figure 89: Asia Pacific Market Value Share (%) and BPS Analysis by Mode of Mechanism, 2023 to 2033
Figure 90: Asia Pacific Market Y-o-Y Growth (%) Projections by Mode of Mechanism, 2023 to 2033
Figure 91: Asia Pacific Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 92: Asia Pacific Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 93: Asia Pacific Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 94: Asia Pacific Market Value (US$ Million) Analysis by End-use, 2018 to 2033
Figure 95: Asia Pacific Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033
Figure 96: Asia Pacific Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033
Figure 97: Asia Pacific Market Attractiveness by Mode of Mechanism, 2023 to 2033
Figure 98: Asia Pacific Market Attractiveness by Application, 2023 to 2033
Figure 99: Asia Pacific Market Attractiveness by End-use, 2023 to 2033
Figure 100: Asia Pacific Market Attractiveness by Country, 2023 to 2033
Figure 101: MEA Market Value (US$ Million) by Mode of Mechanism, 2023 to 2033
Figure 102: MEA Market Value (US$ Million) by Application, 2023 to 2033
Figure 103: MEA Market Value (US$ Million) by End-use, 2023 to 2033
Figure 104: MEA Market Value (US$ Million) by Country, 2023 to 2033
Figure 105: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033
Figure 106: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033
Figure 107: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033
Figure 108: MEA Market Value (US$ Million) Analysis by Mode of Mechanism, 2018 to 2033
Figure 109: MEA Market Value Share (%) and BPS Analysis by Mode of Mechanism, 2023 to 2033
Figure 110: MEA Market Y-o-Y Growth (%) Projections by Mode of Mechanism, 2023 to 2033
Figure 111: MEA Market Value (US$ Million) Analysis by Application, 2018 to 2033
Figure 112: MEA Market Value Share (%) and BPS Analysis by Application, 2023 to 2033
Figure 113: MEA Market Y-o-Y Growth (%) Projections by Application, 2023 to 2033
Figure 114: MEA Market Value (US$ Million) Analysis by End-use, 2018 to 2033
Figure 115: MEA Market Value Share (%) and BPS Analysis by End-use, 2023 to 2033
Figure 116: MEA Market Y-o-Y Growth (%) Projections by End-use, 2023 to 2033
Figure 117: MEA Market Attractiveness by Mode of Mechanism, 2023 to 2033
Figure 118: MEA Market Attractiveness by Application, 2023 to 2033
Figure 119: MEA Market Attractiveness by End-use, 2023 to 2033
Figure 120: MEA Market Attractiveness by Country, 2023 to 2033
